Subscribe to Newsletter

Trends & Forecasts

Business & Regulation Trends & Forecasts

Our Videos: The Greatest Hits

| 1 min read

From gene therapy to novel excipients to trends in leadership and more. Check out some of our most popular videos.

Manufacture Bioprocessing - Upstream & Downstream

The Era of Antibody 2.0

| 2 min read

Experts look at trends in antibody drug development, including the growing popularity of new modalities.

Manufacture Technology and Equipment

Using AI to Conquer the Undruggable

| 2 min read

AI is set to be a key disruptor in the pharma industry. Here are two perspectives on how it could change drug development.

Discovery & Development Clinical Trials

Asking the Right Questions in R&D

| 3 min read

And getting the right people involved from the start. Here’s why collaboration is key for successful clinical development.

Business & Regulation Trends & Forecasts

mRNA Trend Setters

| 2 min read

Why mRNA will be a key disrupter in the coming years; experts from CureVac and Omega Therapeutics give their views.

Manufacture Advanced Medicine

Meet the California Institute Pushing Stem Cell & Gene Therapy Research: Part 3

| Stephanie Vine | 6 min read

Welcome back to our interview series with Jon Thomas, President and CEO of the California Institute for Regenerative Medicine: CIRM.

Business & Regulation Trends & Forecasts

The Arrival and Maturity of Personalized Medicine and AI

| 2 min read

What lies ahead for the future of pharma? Dennis van Rooji gives his view.

Manufacture Advanced Medicine

Fear Replaced by Understanding, Optimism, and Miracles: Part II

| Daniel Eisenman | 7 min read

Accelerating the progress of cell and gene therapies with decentralized trials and other innovative approaches.

Business & Regulation Digital Technologies

The Three Pillars of AI

| 4 min read

AI helps make preclinical decisions faster, but stakeholders remain cautious. We asked an expert from Elsevier for their views on the challenges.

Business & Regulation Trends & Forecasts

Cutting Down the Decades in Drug Development

| 2 min read

New medicines save lives, but they take too long to get to market. Could AI make a difference?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

May Issue of The Medicine Maker